Familial Dysautonomia Recruiting Phase 2 Trials for Phosphatidyl serine (DB00144)

Also known as: Riley-Day syndrome / Dysautonomia, Familial / Familial dysautonomia [Riley-Day] / HSAN III

IndicationStatusPhase
DBCOND0048634 (Familial Dysautonomia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02276716The Nutritional Supplement Phosphatidylserine in Patients With Familial DysautonomiaTreatment